Doylestown, PA, United States of America

Steven Jay Adelman

This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: American Home Products Corporation, Wake Forest University, Nanophagix LLC. Active years: 1995-2025.

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 92.3

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 115(Granted Patents)

Location History:

Montgomery, PA (US) (1996)
Hatfield, PA (US) (1996 - 2001)
Doylestown, PA (US) (1995 - 2021)

Company Filing History:

8 out of 1,567

American Home Products Corporation

patents

3 out of 524

Wake Forest University

5. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12344619 - Drug delivery and imaging chemical conjugate, formulations and methods of use thereof (2025-07-01),

2. 11034701 - Drug delivery and imaging chemical conjugate, formulations and methods of use thereof (2021-06-15),

3. 7022688 - Use of 17β-dihydroequilenin as an antioxidant (2006-04-04),

4. 6670355 - Method of treating cardiovascular disease (2003-12-30),

5. 6271221 - Use of equilenin as an antioxidant (2001-08-07),

6. 6207659 - Effects of 17 &agr;-dihydroequilenin on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals (2001-03-27),

7. 6147069 - Effects of 17.alpha.-dihydroequilenin on plasma lipid and lipoprotein, (2000-11-14),

8. 5994337 - Effects of 17.alpha.-dihydroequilenin on plasma lipid and lipoprotein, (1999-11-30),

9. 5552395 - .DELTA.9(11)-dehydro-8-isoestrone used to treat alzheimer's disease (1996-09-03),

10. 5510342 - Method of lowering cholesterol (1996-04-23),

11. 5496814 - Method of modifying bone resorption with (1996-03-05),

12. 5482935 - Anti-atherosclerotic use of 17 alpha-dihydroequilin (1996-01-09),

13. 5395831 - Treating cardiac disorders with .DELTA.9(11)-dehydro-8-isoestrone (1995-03-07),

Title: Steven Jay Adelman: Innovator in Drug Delivery and Imaging

Introduction

Steven Jay Adelman is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of drug delivery and imaging, holding a total of 13 patents. His work focuses on developing compounds that can effectively enter macrophages and modulate the activity of the mammalian target of rapamycin (mTor).

Latest Patents

Adelman's latest patents include innovations related to drug delivery and imaging chemical conjugates. These inventions involve compounds capable of entering macrophages and modulating mTor activity, which is crucial for treating mTor-associated diseases. His work also encompasses methods for imaging mTor in subjects, particularly within macrophages.

Career Highlights

Throughout his career, Steven Jay Adelman has worked with prominent organizations such as American Home Products Corporation and Wake Forest University. His experience in these institutions has contributed to his expertise in the field of drug delivery and imaging technologies.

Collaborations

Adelman has collaborated with notable individuals in his field, including Scott A Washburn and Thomas B Clarkson. These partnerships have likely enhanced his research and development efforts.

Conclusion

Steven Jay Adelman is a distinguished inventor whose work in drug delivery and imaging has the potential to impact the treatment of various diseases. His innovative approaches and collaborations continue to advance the field of medical science.